The market wants to see ARR growth without a subsequent CR, we get that, our Sherpa starts climbing Everest to the summit
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025